We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBEV.WS
276
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
– –
-904,000
Closed -$17.3K
SBUX icon
277
Starbucks
SBUX
$120B
– –
-320,126
Closed -$29.2M
SIG icon
278
Signet Jewelers
SIG
$3.76B
– –
-14,808
Closed -$1.2M
SRZN icon
279
Surrozen
SRZN
$301M
– –
-75,694
Closed -$1.09M
SKYAW
280
SkyAI Inc
SKYAW
$263K
– –
-53,454
Closed -$2.15K
SVREW
281
SaverOne 2014 Ltd Warrant
SVREW
– –
-13,450
Closed -$269
SXTP icon
282
60 Degrees Pharmaceuticals
SXTP
$2.98M
– –
-4,947
Closed -$128K
THS
283
DELISTED
Treehouse Foods
THS
– –
-675,440
Closed -$23.7M
TMO icon
284
Thermo Fisher Scientific
TMO
$220B
– –
-20,044
Closed -$10.4M
XRTX
285
XORTX Therapeutics
XRTX
$3.69M
– –
-53,000
Closed -$299K
ZGN icon
286
Zegna
ZGN
$4B
– –
-242,000
Closed -$2M
VIVS
287
VivoSim Labs
VIVS
$1.64M
– –
-136,554
Closed -$754K
CMRX
288
DELISTED
Chimerix, Inc.
CMRX
– –
-2,236,000
Closed -$7.78M
NVRO
289
DELISTED
NEVRO CORP.
NVRO
– –
-3,736,000
Closed -$13.9M
TCBPW
290
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
– –
-188
Closed -$2
NARI
291
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-1,565,577
Closed -$79.9M
SNAX
292
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
– –
-35,139
Closed -$22.6K
VINC
293
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-28,351
Closed -$149K
AWH
294
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
– –
-710,000
Closed -$501K
BPTH
295
DELISTED
Bio-Path Holdings Inc
BPTH
– –
-237,561
Closed -$276K
8 9 10 11
12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.